Suchergebnisse - "Personeni, Nicola"

PubPharm (8)

1

Trifluridine-Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer

enthalten in: The New England journal of medicine | 2023

von Prager, G. | Taieb, J. | Fakih, M. | +118

CommentIn: Nat Rev Clin Oncol. 2023 Aug;20(8):504. - PMID 37198414

2

Italian results of the PRECONNECT study : safety and efficacy of trifluridine/tipiracil in metastatic colorectal cancer

enthalten in: Future oncology (London, England) | 2021

von Zaniboni, A. | Barone, C. | Banzi, M. | +17

3

Tivantinib for second-line treatment of MET-high, advanced hepatocellular carcinoma (METIV-HCC) : a final analysis of a phase 3, randomised, placebo-controlled study

enthalten in: The Lancet. Oncology | 2018

von Rimassa, L. | Assenat, E. | Peck-Radosavljevic, M. | +27

CommentIn: Lancet Oncol. 2018 May;19(5):591-592. - PMID 29625880

4

Tumor and circulating biomarkers in patients with second-line hepatocellular carcinoma from the randomized phase II study with tivantinib

enthalten in: Oncotarget | 2016

von Rimassa, L. | Abbadessa, G. | Personeni, N. | +17

5

FOLFIRI and Cetuximab Every Second Week for First-Line Treatment of KRAS Wild-Type Metastatic Colorectal Cancer According to Phosphatase and Tensin Homolog Expression : A Phase II Study

enthalten in: Clinical colorectal cancer | 2015

von Personeni, N. | Rimassa, L. | Verusio, C. | +13

6

Tivantinib for second-line treatment of advanced hepatocellular carcinoma : a randomised, placebo-controlled phase 2 study

enthalten in: The Lancet. Oncology | 2013

von Santoro, A. | Rimassa, L. | Borbath, I. | +25

CommentIn: Lancet Oncol. 2013 Jan;14(1):7-8. - PMID 23182626

7

A phase II randomized dose escalation trial of sorafenib in patients with advanced hepatocellular carcinoma

enthalten in: The oncologist | 2013

von Rimassa, L. | Pressiani, T. | Boni, C. | +14

8

Phase III trial comparing protracted intravenous fluorouracil infusion alone or with yttrium-90 resin microspheres radioembolization for liver-limited metastatic colorectal cancer refractory to standard chemotherapy

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2010

von Hendlisz, A. | Van den Eynde, M. | Peeters, M. | +13

1
[1]